Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance?

By sjmartinez • June 21, 2023

Chester RC, Parikh RV. Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance? Circ Cardiovasc Interv. 2023 Jun;16(6):e013113. doi: 10.1161/CIRCINTERVENTIONS.123.013113. Epub 2023 Jun 20. PMID: 37339236.

Tags: angiography, Cardiology/Epi, coronary artery disease, drug-eluting stents, Editorials, percutaneous coronary intervention, Publications

Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis

Hoffman R, Watanabe M, Martínez E, Zanni MV, Pozniak A, Shakil SS, McCallum S, Chu SM, Srinivasa S, Malvestutto CD, Fichtenbaum CJ, Bloomfield GS, Lu[...]

Lipids and lipoproteins in calcific aortic valve disease

Aksoy O, Tintut Y, Demer LL. Lipids and lipoproteins in calcific aortic valve disease. Curr Opin Lipidol. 2026 Oct 1;37(5):185-190. doi: 10.1097/MOL.0000000000001053. Epub 2026 Aug[...]

Lipids in endothelial-to-mesenchymal transition

Tripsas CK, Tsai AY, Hsu JJ. Lipids in endothelial-to-mesenchymal transition. Curr Opin Lipidol. 2026 Oct 1;37(5):177-184. doi: 10.1097/MOL.0000000000001051. Epub 2026 Aug 12. PMID: 42592967.